About Vivus
Vivus is a company based in Mountain View (United States) founded in 1991.. The company has 59 employees as of February 29, 2020. Vivus offers products and services including PANCREAZE and QSYMIA. Vivus operates in a competitive market with competitors including Actelion, Adocia, Altimmune, Carmot and BioAge Labs, among others.
- Headquarter Mountain View, United States
- Employees 59 as on 29 Feb, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivus Llc
-
Annual Revenue
$69.76 M7as on Dec 31, 2019
-
Net Profit
$-31.5 M15as on Dec 31, 2019
-
EBITDA
$-10.97 M-215as on Dec 31, 2019
-
Latest Funding Round
$253 M (USD), Post-IPO
May 01, 2013
- Investors
-
Employee Count
59
as on Feb 29, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivus
Vivus offers a comprehensive portfolio of products and services, including PANCREAZE and QSYMIA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manages Exocrine Pancreatic Insufficiency to reduce diarrhea and malnutrition.
Supports weight management through clinical treatment for obesity.
Unlock access to complete
Sales and Marketing
17 people
Leadership Team
6 people
Software Development Team
4 people
Human Resources and Administration
2 people
Data Analysis and Operations Team
2 people
Legal and Compliance
2 people
Product Management Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Vivus
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $253.0M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2013 | Amount | Post-IPO - Vivus | Valuation |
investors |
|
| Jun, 1993 | Amount | Unspecified - Vivus | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vivus
Vivus has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vivus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivus Comparisons
Competitors of Vivus
Vivus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, Adocia, Altimmune, Carmot and BioAge Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vivus
Frequently Asked Questions about Vivus
When was Vivus founded?
Vivus was founded in 1991 and raised its 1st funding round 2 years after it was founded.
Where is Vivus located?
Vivus is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
How many employees does Vivus have?
As of Feb 29, 2020, the latest employee count at Vivus is 59.
What is the annual revenue of Vivus?
Annual revenue of Vivus is $69.76M as on Dec 31, 2019.
What does Vivus do?
Vivus was established in 1991 in Mountain View, United States, within the pharmaceutical sector. Drug development and commercialization efforts are centered on treatments for obesity and sexual health conditions. A pipeline program featuring Tacrolimus is directed toward pulmonary arterial hypertension management. Operations encompass research, clinical trials, and market introduction of these therapies across the United States.
Who are the top competitors of Vivus?
Vivus's top competitors include Adocia, BioAge Labs and Fractyl.
What products or services does Vivus offer?
Vivus offers PANCREAZE and QSYMIA.
Who are Vivus's investors?
Vivus has 1 investor. Key investors include Frazier Healthcare Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.